How should a patient with second-degree atrioventricular (AV) block Mobitz type II be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Mobitz Type II Second-Degree AV Block

Mobitz type II second-degree AV block is an indication for permanent pacemaker implantation, as this rhythm is invariably located in the His-Purkinje system and carries significant risk of progression to complete heart block. 1, 2

Immediate Assessment and Stabilization

Acute Symptomatic Presentation

If the patient presents with symptomatic bradycardia (altered mental status, chest pain, heart failure, hypotension, or shock):

  • Avoid atropine - it is ineffective for Mobitz type II block because the conduction disturbance is infranodal (below the AV node), not responsive to vagal blockade 3
  • Initiate transcutaneous pacing (TCP) immediately as a temporizing measure 3
  • Prepare for transvenous temporary pacing while arranging permanent pacemaker implantation 3, 4

Diagnostic Confirmation

Before proceeding with permanent pacing, confirm true Mobitz type II block by verifying:

  • Constant PR intervals before and after the blocked P wave (unchanged PR interval is sine qua non) 5, 6
  • Stable sinus rate - vagal surges can cause simultaneous sinus slowing and AV nodal block that mimics type II block but is benign 5, 6
  • Distinguish from 2:1 AV block - this pattern cannot be classified as type I or II and may require stress testing or electrophysiology study (EPS) to differentiate 2:1 Wenckebach from true Mobitz type II 1
  • Rule out pseudo-AV block from concealed His bundle or ventricular extrasystoles 5, 7

Comprehensive Evaluation

Perform the following workup regardless of symptoms 1:

  • History and physical examination - assess for syncope, presyncope, exercise intolerance, heart failure symptoms
  • 12-lead ECG - evaluate QRS duration and bundle branch block patterns
  • Echocardiogram - identify structural heart disease
  • Exercise stress test - may help distinguish 2:1 Wenckebach from true Mobitz type II 1

Permanent Pacemaker Indications

Standard Indication (Class I)

Permanent pacemaker implantation is indicated for all patients with correctly diagnosed Mobitz type II block 1, 2, 8. This applies whether the patient is:

  • Symptomatic or asymptomatic
  • Has narrow or wide QRS complex
  • Young or elderly

The rationale: Mobitz type II block is invariably infranodal, carries high risk of progression to complete heart block with slow, unreliable escape rhythms, and has been associated with sudden death 9, 8, 6, 7.

Special Context: Acute Myocardial Infarction

In the setting of acute MI with Mobitz type II block 2, 10:

  1. Temporary pacing is indicated for symptomatic or hemodynamically significant bradycardia
  2. Waiting period required before permanent pacing to allow for potential resolution
  3. Permanent pacing indicated if Mobitz type II block is persistent or infranodal after the waiting period 2, 10

Important caveat: Mobitz type II block has not been reported in inferior MI - if you see apparent type II block in this setting, it is likely misdiagnosed type I block 6.

Special Context: Post-Cardiac Surgery

In adult congenital heart disease or post-surgical patients 2, 11:

  • Permanent pacing recommended for postoperative Mobitz type II block that persists beyond 7-10 days or is not expected to resolve
  • Consider epicardial leads in patients with intracardiac shunts or single ventricle physiology to avoid thromboembolic risk 2, 11

Common Diagnostic Pitfalls

Misdiagnosis of Atypical Wenckebach as Mobitz Type II

Atypical Wenckebach with minimal PR prolongation before the block can mimic Mobitz type II 5, 12, 6. Key distinguishing features:

  • Wenckebach: May show RP-dependent PR intervals or RP-PR reciprocity 12
  • True Mobitz type II: Absolutely constant PR intervals, no relationship to preceding cycle length
  • If you see both apparent "type II" and obvious type I patterns in the same recording (e.g., Holter), this effectively rules out true type II block 6, 7

Wide QRS Does Not Equal Mobitz Type II

A type I (Wenckebach) block with bundle branch block is infranodal in 60-70% of cases and also requires pacing 8, 6, 7. The critical distinction is the pattern of PR intervals, not QRS width.

Monitoring Requirements

Until permanent pacemaker placement 13, 9:

  • Continuous telemetry monitoring is mandatory
  • Mobitz type II block can progress rapidly and unpredictably to complete heart block with slow, unreliable escape rhythms
  • Have transcutaneous pacing pads readily available

Bottom Line Algorithm

  1. Confirm diagnosis: Constant PR intervals + stable sinus rate + blocked P wave
  2. Assess hemodynamics: If unstable → TCP immediately
  3. Evaluate for reversible causes: Acute MI, drugs, electrolytes
  4. Arrange permanent pacemaker: This is definitive therapy regardless of symptoms
  5. Monitor continuously until pacemaker implanted

The management is straightforward because correctly identified Mobitz type II block is always an indication for permanent pacing - there is no role for observation or medical management alone 1, 2, 8.

References

6
Research

Second-degree atrioventricular block revisited.

Herzschrittmachertherapie & Elektrophysiologie, 2012

7
Research

Second-degree atrioventricular block: a reappraisal.

Mayo Clinic proceedings, 2001

Related Questions

How can I differentiate a 2:1 atrioventricular (AV) block from Mobitz type II and determine the appropriate management?
In second-degree atrioventricular block, are QRS complexes dropped?
How should I describe second-degree atrioventricular (AV) block to a patient?
Are there benign causes of Mobitz type II atrioventricular block?
What causes a 2nd degree (second degree) heart block?
In an elderly patient with recent Enterococcus faecalis urinary tract infection, bacteremia, and endocarditis, a 4 mm aortic bioprosthetic valve opacity, now presenting with painful palpable purpura that has progressed to bullae and new transaminitis while on daptomycin, who previously received intravenous ampicillin and ceftriaxone (Rocephin) and has a history of transcatheter aortic valve replacement (TAVR) with pacemaker, atrial fibrillation on apixaban (Eliquis), and daily furosemide with as‑needed potassium supplementation, how should I work up and manage the suspected drug‑induced bullous leukocytoclastic vasculitis versus other vasculitic etiologies from a pharmacy standpoint?
For an 85-year-old patient with severe systolic heart failure (ejection fraction 15%) and a documented do‑not‑intubate order who is now hypoxic, and whose healthcare proxy insists on intubation, what is the next best step?
How should Curasept (0.12% chlorhexidine gluconate) mouthwash be used, including dosage, frequency, duration, and contraindications?
In a patient with an ischemic stroke secondary to non‑valvular atrial fibrillation, should an antiplatelet agent be added to oral anticoagulation therapy?
What is the recommended tapering schedule to discontinue pregabalin in a patient without epilepsy?
What are the antibiotics of choice for treating a breast abscess in a postpartum patient after a lower‑segment cesarean section (LSCS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.